COVID-19 is now announced pandemic by the World Health Organization (WHO) causing many countries to declare emergency state and shutdown public places. Diagnostic tools can play a key role in decreasing the spreading rate and controlling the virus. Microfluidics has the potential to offer rapid...
A major challenge in cancer therapy is tumor-targeted drug delivery. Targeted drug delivery refers to the accumulation of a drug near a specific zone to maximize the therapeutic effect. Over the years various strategies have been developed to increase the efficiency of the targeted drug delivery...
The blood-brain barrier (BBB) is a mechanism in the periphery of the central nervous system that protects the nervous system from external substances as well as hormones and neurotransmitters released in other parts of the body. This highly selective and semi-permeable membrane is essential in...
Prostate cancer is one of the most common cancers among men. Early detection of prostate cancer prevents malignancy and leads to a nearly 100% survival rate whereas late diagnosis reduces it to ~28%. Currently, the gold standard for testing prostate cancer is measuring the prostate-specific...
Although CRISPR technology is well-known for its ability for gene knock-out and therapeutic applications, it has been recently evolved as a powerful technique for diagnostics purposes. The strength of CRISPR diagnostics methods along with the superiority of microfluidics technology in manufacturing point-of-care (POC) diagnostics chips...